are several highly efficient PET imaging agents already available for imaging hD2R.
Next, the authors chose a transfection method for inserting this mutated gene into the hMPCs.
An adenoviral construct was used to transfect cells with the mutated hD2R gene. After transfection, hD2R-transfected cells showed no signs of toxicity and the proliferation rate of transfected hMPCs remained unchanged. Together, these data verified the simplicity and high efficiency of the adenoviral system for rapid transfection of the hD2R gene into hMPCs. tracer uptake is dependent upon the availability of targeted cells, the injected tracer dose, the regional blood flow and vascularity of the tissue, and the pharmacokinetics of tracer uptake (7). It was previously described that reporter genes encoding for intracellular enzymes or transporters show superiority over membrane receptors like hD2R as they allow the tracer to accumulate inside the cell, whereas binding to surface receptors may be weak and reversible (8) . In addition to the dopamine model described in this study, the sodium-iodide symporter transfection model is an alternative model which has been commonly employed for PET or SPECT imaging (9) . transplanted cells with high specificity using PET or other imaging modalities may eliminate the necessity for highly invasive procedures. As researchers continue to investigate novel cell-based therapies, molecular imaging must continue to evolve to support the need for non-invasive imaging approaches. This field holds great promise, and we expect that cell-based therapies will become a vital part of personalized medicine for the treatment of a broad range of diseases in the future.
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